Cell-free fetal nucleic acids for non-invasive prenatal diagnosis
is the result of a project funded and led by the PHG Foundation. An expert Working Group including GPs, obstetricians, midwives, geneticists, NHS commissioners, public health experts, ethicists and patient representatives met over the course of 2008 to consider the use of cell-free fetal nucleic acid technology for non-invasive prenatal diagnosis (NIPD). In addition to the current scientific and clinical status of the technology, they also looked at ethical, social and legal implications, and key issues associated with implementation in the NHS.
This report was presented to the Joint Committee on Medical Genetics (JCMG) of the Royal College of Physicians in January 2009.
How to reference this report: Wright, C. Cell-free fetal nucleic acids for non-invasive prenatal diagnosis, Report of the UK expert working group, PHG Foundation (2009)
Report appendix III: Ethical, legal and social issues associated with the use of cell-free fetal nucleic acids for non-invasive prenatal diagnosis
For further information about the report, please contact Dr Philippa Brice.
For members of the media, full quotes about the report and contact details for selected key members of the working group are available; please contact the PHG Foundation press office on 07505092081.